Abstract
In recent years, deep neural networks, especially those exhibiting synergistic properties, have been at the cutting edge of image processing, producing very good results. So far, they have been able to successfully address issues of classification and recognition of objects depicted on images. In this paper, a novel idea is presented, where images of chemical structures are used as input information in deep learning neural network architectures aiming at the generation of Quantitative Structure Activity Relationship (QSAR) models, i.e. models that predict properties, activities or adverse effects of chemicals. The proposed method was applied to a case study of particular interest, which is the prediction of endocrine disrupting potential of chemicals. Two different deep learning architectures were applied. The produced ImageNet model proved successful, in terms of accuracy, performance and robustness on training and validation sets. The new approach is proposed to the community as an alternative or complementary method to current practices in QSAR modelling, which can automate and improve the creation of predictive models.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
No
Funding Statement
no external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email addresses: pantelispanka{at}gmail.com (Pantelis Karatzas), petrosstefaneas{at}gmail.com (Petros Stefaneas), hsarimv{at}central.ntua.gr (Haralambos Sarimveis), yiannis.kiouvrekis{at}gmail.com (Yiannis Kiouvrekis)
Data Availability
The data that support the findings of this study are available from the first author, [PK], upon reasonable request.
